Want to see ASMB full AI Analyst Report?
Assembly Biosciences (ASMB) Income Statement
Assembly Biosciences Income Statement
Last quarter (Q2 2026), Assembly Biosciences's total revenue was $13.37M, an increase of 38.94% from the same quarter last year. In Q2, Assembly Biosciences's net income was $-3.86M. See Assembly Biosciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 72.30M | $ 28.52M | $ 7.16M | $ 0.00 | $ 6.25M | |
| $ 72.17M | $ -27.41M | $ -41.74M | $ -69.08M | $ 6.25M | |
| $ 84.42M | $ 18.01M | $ 22.91M | $ 25.03M | $ 138.94M | |
| Depreciation and Amortization | $ 129.00K | $ 129.00K | $ 450.00K | $ 498.00K | $ 466.00K |
| $ -5.99M | $ -39.72M | $ -60.74M | $ -92.52M | $ -90.58M | |
| $ -12.12M | $ -45.42M | $ -64.65M | $ -94.11M | $ -132.69M | |
| $ 6.00M | $ 5.57M | $ 3.45M | $ 1.02M | $ 302.00K | |
| $ -6.12M | $ -39.85M | $ -61.20M | $ -93.09M | $ -132.39M | |
| $ -6.12M | $ -40.18M | $ -61.23M | $ -93.09M | $ -129.85M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.55 | $ -6.69 | $ -13.38 | $ -22.82 | $ -36.00 |
| Diluted EPS | $ -0.55 | $ -6.69 | $ -13.38 | $ -22.82 | $ -36.00 |
| Weighted Average Shares Outstanding | 11.21M | 6.00M | 4.58M | 4.03M | 3.61M |
| Weighted Average Shares Outstanding (Diluted) | 11.21M | 6.00M | 4.58M | 4.03M | 3.61M |
Currency in USD